Improving management of preterm premature rupture of membranes with antibiotics
Official title: Improvement of PPROM Management With Prophylactic Antimicrobial Therapy
Run by Ohio State University · NCT06396078 · Data updated 2026-11-12
This study is testing if a new combination of antibiotics can help pregnant people with preterm premature rupture of membranes stay pregnant longer and have healthier babies compared to the usual treatment.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 56 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 2 sites (Columbus, Ohio and 1 other locations) |
| Status | Recruiting |
| Started | July 18, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT06396078 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant individuals aged 18 and older, between 23 and 32 weeks of gestation, who are admitted for expectant management of PPROM.
✕Probably not a fit
Patients who have received more than one dose of prophylactic antibiotics or have a suspected or confirmed infection requiring treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of a new antibiotic regimen consisting of ceftriaxone, clarithromycin, and metronidazole compared to the standard treatment of ampicillin/amoxicillin and azithromycin or erythromycin for pregnant individuals with preterm premature rupture of membranes (PPROM). The study aims to prolong pregnancy and reduce adverse perinatal outcomes by administering these antibiotics during hospitalization for expectant management. Participants will be randomly assigned to receive either treatment for a duration of seven days, and outcomes will be monitored to assess the efficacy of the new regimen. The trial is designed as an unblinded pragmatic randomized controlled trial to reflect real-world clinical practice.
Why it matters
Potential benefit: If successful, this study could lead to improved pregnancy outcomes and reduced complications for patients with PPROM.
How similar studies have gone: Previous observational studies have shown success with similar antibiotic regimens, indicating potential for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Admitted to the inpatient unit for expectant management of PPROM until delivery * Age ≥ 18 years with the ability to provide informed consent * Gestational age between 23 0/7 and 32 6/7 weeks Exclusion criteria * Having received more than one dose of any prophylactic antibiotic * Suspected or confirmed infection requiring treatment with antibiotics * Allergy or contraindication to an antibiotic in either arm * Maternal immunosuppression
Where it's running
-
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio, United States Recruiting -
University of Texas Medical Branch
Galveston, Texas, United States Recruiting
Study contacts
- Principal investigator: Marissa Berry, MD — Ohio State University
- Study coordinator: Marissa Berry, MD
- Email: Marissa.Berry@osumc.edu
- Phone: 614-293-4780
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Selective antibiotics when symptoms develop versus universal antibiotics for preterm neonates
In preterm babies at risk for sepsis, researchers test whether giving antibiotics only to those who show symptoms is as safe as giving antibiotics to all at-risk babies in the first week of life.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Cervical stiffness test to help predict preterm birth in at-risk pregnant women
A simple cervical stiffness test using the Pregnolia device is being studied to see if it can better identify women with threatened preterm labor who are likely to give birth soon.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
How doctors and nurses decide about bed rest in pregnancy
This study tests a plan to stop routinely restricting activity or bed rest during pregnancy to see if providers accept it, find it appropriate, and change how often they recommend it for women at risk of preterm birth.
-
How cervical ultrasound settings affect AI prediction of preterm birth
This study tests whether an AI model for predicting preterm birth performs differently when cervical ultrasound images are taken with different imaging settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.